2023-2029 Global Assisted Reproductive Drugs Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 136 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Assisted Reproductive Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Assisted Reproductive Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Assisted Reproductive Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Ovulation Stimulation Drugs segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Assisted Reproductive Drugs include Merck Serono, MSD, Livzon Pharmaceutical, Xianju Pharmaceutical and Kinsey Pharmaceuticals, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Assisted reproductive drugs include ovulation-stimulating drugs, luteal support drugs, down-regulatory drugs, ovulation-inducing drugs, etc. From the perspective of the use of various drugs in the IVF process, ovulation-stimulating drugs accounted for the highest proportion, as high as 62%, luteal support drugs accounted for 20%, down-regulatory drugs accounted for 15%, and ovulation-inducing drugs accounted for 3%.
This report aims to provide a comprehensive study of the global market for Assisted Reproductive Drugs. Report Highlights:
(1) Global Assisted Reproductive Drugs market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Assisted Reproductive Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Assisted Reproductive Drugs market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Assisted Reproductive Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Assisted Reproductive Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Assisted Reproductive Drugs, capacity, production and trends.
(7) Assisted Reproductive Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Ovulation Stimulation Drugs
Luteal Support Medications
Downregulatory Drugs
Ovulation Inducing Drugs
Market segment by application, can be divided into
Hospital
Medical Institutions
Research Institute
Others
Market segment by players, this report covers
Merck Serono
MSD
Livzon Pharmaceutical
Xianju Pharmaceutical
Kinsey Pharmaceuticals

1 Market Overview
1.1 Assisted Reproductive Drugs Definition
1.2 Global Assisted Reproductive Drugs Market Size and Forecast
1.2.1 By Revenue, Global Assisted Reproductive Drugs Market Size, 2018-2029
1.2.2 By Sales Volume, Global Assisted Reproductive Drugs Market Size, 2018-2029
1.2.3 Global Assisted Reproductive Drugs Price Trend, 2018-2029
1.3 China Assisted Reproductive Drugs Market Size and Forecast
1.3.1 By Revenue, China Assisted Reproductive Drugs Market Size, 2018-2029
1.3.2 By Sales Volume, China Assisted Reproductive Drugs Market Size, 2018-2029
1.3.3 China Assisted Reproductive Drugs Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Assisted Reproductive Drugs Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Assisted Reproductive Drugs Share in Global Market, 2018-2029
1.4.3 Assisted Reproductive Drugs Market Size: China VS Global, 2018-2029
1.5 Assisted Reproductive Drugs Market Dynamics
1.5.1 Assisted Reproductive Drugs Market Drivers
1.5.2 Assisted Reproductive Drugs Market Restraints
1.5.3 Assisted Reproductive Drugs Industry Trends
1.5.4 Assisted Reproductive Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Assisted Reproductive Drugs Revenue by Company, 2018-2023
2.2 Global Assisted Reproductive Drugs Sales Volume by Company, 2018-2023
2.3 Global Assisted Reproductive Drugs Price by Company, 2018-2023
2.4 Global Assisted Reproductive Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Assisted Reproductive Drugs Concentration Ratio
2.6 Global Assisted Reproductive Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Assisted Reproductive Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Assisted Reproductive Drugs Revenue by Company, 2018-2023
3.2 China Assisted Reproductive Drugs Sales Volume by Company, 2018-2023
3.3 China Assisted Reproductive Drugs Assisted Reproductive Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Assisted Reproductive Drugs Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Assisted Reproductive Drugs Domestic VS Export
3.6 China Market, Assisted Reproductive Drugs Import & Export
3.6.1 China Market, Assisted Reproductive Drugs Import & Export, 2018-2029
3.6.2 China Assisted Reproductive Drugs Import & Export Trends
3.6.3 Main Sources of China Assisted Reproductive Drugs Import
3.6.4 Export Destination of China Assisted Reproductive Drugs
4 Assisted Reproductive Drugs Production by Region
4.1 Global Assisted Reproductive Drugs Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Assisted Reproductive Drugs Manufacturers
4.3 Global Major Manufacturers, Assisted Reproductive Drugs Capacity Expansion and Future Plans
4.4 Global Assisted Reproductive Drugs Capacity by Region
4.5 Global Assisted Reproductive Drugs Production by Region
4.5.1 Global Assisted Reproductive Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Assisted Reproductive Drugs Production by Region, 2018-2023
4.5.3 Global Assisted Reproductive Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Assisted Reproductive Drugs Industry Chain
5.2 Assisted Reproductive Drugs Upstream Analysis
5.2.1 Assisted Reproductive Drugs Core Raw Materials
5.2.2 Main Manufacturers of Assisted Reproductive Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Assisted Reproductive Drugs Production Mode
5.6 Assisted Reproductive Drugs Procurement Model
5.7 Assisted Reproductive Drugs Industry Sales Model and Sales Channels
5.7.1 Assisted Reproductive Drugs Sales Model
5.7.2 Assisted Reproductive Drugs Typical Distributors
6 Sights by Type
6.1 Assisted Reproductive Drugs Classification
6.1.1 Ovulation Stimulation Drugs
6.1.2 Luteal Support Medications
6.1.3 Downregulatory Drugs
6.1.4 Ovulation Inducing Drugs
6.2 By Type, Global Assisted Reproductive Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Assisted Reproductive Drugs Revenue, 2018-2029
6.4 By Type, Global Assisted Reproductive Drugs Sales Volume, 2018-2029
6.5 By Type, Global Assisted Reproductive Drugs Price, 2018-2029
7 Sights by Application
7.1 Assisted Reproductive Drugs Segment by Application
7.1.1 Hospital
7.1.2 Medical Institutions
7.1.3 Research Institute
7.1.4 Others
7.2 By Application, Global Assisted Reproductive Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Assisted Reproductive Drugs Revenue, 2018-2029
7.4 By Application, Global Assisted Reproductive Drugs Sales Volume, 2018-2029
7.5 By Application, Global Assisted Reproductive Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Assisted Reproductive Drugs Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Assisted Reproductive Drugs Revenue, 2018-2029
8.3 By Region, Global Assisted Reproductive Drugs Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Assisted Reproductive Drugs Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Assisted Reproductive Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Assisted Reproductive Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Assisted Reproductive Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Assisted Reproductive Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Assisted Reproductive Drugs Market Size Market Share
8.7 South America
8.7.1 South America Assisted Reproductive Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Assisted Reproductive Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Assisted Reproductive Drugs Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Assisted Reproductive Drugs Revenue, 2018-2029
9.3 By Country, Global Assisted Reproductive Drugs Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Assisted Reproductive Drugs Market Size, 2018-2029
9.4.2 By Company, U.S. Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Assisted Reproductive Drugs Market Size, 2018-2029
9.5.2 By Company, Europe Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Assisted Reproductive Drugs Market Size, 2018-2029
9.6.2 By Company, China Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Assisted Reproductive Drugs Market Size, 2018-2029
9.7.2 By Company, Japan Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Assisted Reproductive Drugs Market Size, 2018-2029
9.8.2 By Company, South Korea Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Assisted Reproductive Drugs Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Assisted Reproductive Drugs Market Size, 2018-2029
9.10.2 By Company, India Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Assisted Reproductive Drugs Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Assisted Reproductive Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Assisted Reproductive Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck Serono
10.1.1 Merck Serono Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck Serono Assisted Reproductive Drugs Models, Specifications and Application
10.1.3 Merck Serono Assisted Reproductive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Serono Company Profile and Main Business
10.1.5 Merck Serono Recent Developments
10.2 MSD
10.2.1 MSD Company Information, Head Office, Market Area and Industry Position
10.2.2 MSD Assisted Reproductive Drugs Models, Specifications and Application
10.2.3 MSD Assisted Reproductive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 MSD Company Profile and Main Business
10.2.5 MSD Recent Developments
10.3 Livzon Pharmaceutical
10.3.1 Livzon Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.3.2 Livzon Pharmaceutical Assisted Reproductive Drugs Models, Specifications and Application
10.3.3 Livzon Pharmaceutical Assisted Reproductive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Livzon Pharmaceutical Company Profile and Main Business
10.3.5 Livzon Pharmaceutical Recent Developments
10.4 Xianju Pharmaceutical
10.4.1 Xianju Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.4.2 Xianju Pharmaceutical Assisted Reproductive Drugs Models, Specifications and Application
10.4.3 Xianju Pharmaceutical Assisted Reproductive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Xianju Pharmaceutical Company Profile and Main Business
10.4.5 Xianju Pharmaceutical Recent Developments
10.5 Kinsey Pharmaceuticals
10.5.1 Kinsey Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.5.2 Kinsey Pharmaceuticals Assisted Reproductive Drugs Models, Specifications and Application
10.5.3 Kinsey Pharmaceuticals Assisted Reproductive Drugs Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Kinsey Pharmaceuticals Company Profile and Main Business
10.5.5 Kinsey Pharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Assisted Reproductive Drugs Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Assisted Reproductive Drugs Market Restraints
Table 3. Assisted Reproductive Drugs Market Trends
Table 4. Assisted Reproductive Drugs Industry Policy
Table 5. Global Assisted Reproductive Drugs Revenue by Company, 2018-2023, US$ million
Table 6. Global Assisted Reproductive Drugs Revenue Market Share by Company, 2018-2023
Table 7. Global Assisted Reproductive Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Assisted Reproductive Drugs Sales Volume Market Share by Company, 2018-2023
Table 9. Global Assisted Reproductive Drugs Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Assisted Reproductive Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Assisted Reproductive Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Assisted Reproductive Drugs Manufacturers Product Type
Table 13. China Assisted Reproductive Drugs Revenue by Company, 2018-2023, US$ million
Table 14. China Assisted Reproductive Drugs Revenue Market Share by Company, 2018-2023
Table 15. China Assisted Reproductive Drugs Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Assisted Reproductive Drugs Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Assisted Reproductive Drugs Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Assisted Reproductive Drugs Import & Export Trends
Table 19. Main Sources of China Assisted Reproductive Drugs Import
Table 20. Export Destination of China Assisted Reproductive Drugs
Table 21. Global Headquarters and Manufacturing Base of Assisted Reproductive Drugs Manufacturers
Table 22. Global Major Manufacturers, Assisted Reproductive Drugs Capacity Expansion and Future Plans
Table 23. Global Assisted Reproductive Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Assisted Reproductive Drugs Production by Region, 2018-2023, (K Units)
Table 25. Global Assisted Reproductive Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Assisted Reproductive Drugs Upstream (Raw Materials)
Table 27. Global Assisted Reproductive Drugs Typical Customers
Table 28. Assisted Reproductive Drugs Typical Distributors
Table 29. By Type, Global Assisted Reproductive Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Assisted Reproductive Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Assisted Reproductive Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Assisted Reproductive Drugs Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Assisted Reproductive Drugs Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Assisted Reproductive Drugs Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Assisted Reproductive Drugs Revenue Market Share, 2018-2029
Table 37. By Country, Global Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Assisted Reproductive Drugs Sales Volume Market Share, 2018-2029
Table 39. Merck Serono Company Information, Head Office, Market Area and Industry Position
Table 40. Merck Serono Assisted Reproductive Drugs Models, Specifications and Application
Table 41. Merck Serono Assisted Reproductive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Serono Company Profile and Main Business
Table 43. Merck Serono Recent Developments
Table 44. MSD Company Information, Head Office, Market Area and Industry Position
Table 45. MSD Assisted Reproductive Drugs Models, Specifications and Application
Table 46. MSD Assisted Reproductive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. MSD Company Profile and Main Business
Table 48. MSD Recent Developments
Table 49. Livzon Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 50. Livzon Pharmaceutical Assisted Reproductive Drugs Models, Specifications and Application
Table 51. Livzon Pharmaceutical Assisted Reproductive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Livzon Pharmaceutical Company Profile and Main Business
Table 53. Livzon Pharmaceutical Recent Developments
Table 54. Xianju Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 55. Xianju Pharmaceutical Assisted Reproductive Drugs Models, Specifications and Application
Table 56. Xianju Pharmaceutical Assisted Reproductive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Xianju Pharmaceutical Company Profile and Main Business
Table 58. Xianju Pharmaceutical Recent Developments
Table 59. Kinsey Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 60. Kinsey Pharmaceuticals Assisted Reproductive Drugs Models, Specifications and Application
Table 61. Kinsey Pharmaceuticals Assisted Reproductive Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Kinsey Pharmaceuticals Company Profile and Main Business
Table 63. Kinsey Pharmaceuticals Recent Developments
List of Figure
Figure 1. Assisted Reproductive Drugs Picture
Figure 2. By Revenue, Global Assisted Reproductive Drugs Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Assisted Reproductive Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Assisted Reproductive Drugs Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Assisted Reproductive Drugs Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Assisted Reproductive Drugs Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Assisted Reproductive Drugs Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Assisted Reproductive Drugs Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Assisted Reproductive Drugs Share of Global Market, 2018-2029
Figure 10. Global Assisted Reproductive Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Assisted Reproductive Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Assisted Reproductive Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Assisted Reproductive Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Assisted Reproductive Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Assisted Reproductive Drugs Domestic VS Export, 2022
Figure 16. Global Assisted Reproductive Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Assisted Reproductive Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Assisted Reproductive Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 19. Assisted Reproductive Drugs Industry Chain
Figure 20. Assisted Reproductive Drugs Procurement Model
Figure 21. Assisted Reproductive Drugs Sales Model
Figure 22. Assisted Reproductive Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Ovulation Stimulation Drugs
Figure 24. Luteal Support Medications
Figure 25. Downregulatory Drugs
Figure 26. Ovulation Inducing Drugs
Figure 27. By Type, Global Assisted Reproductive Drugs Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Assisted Reproductive Drugs Revenue Market Share, 2018-2029
Figure 29. By Type, Global Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Assisted Reproductive Drugs Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Assisted Reproductive Drugs Price, 2018-2029, (US$/Unit)
Figure 32. Hospital
Figure 33. Medical Institutions
Figure 34. Research Institute
Figure 35. Others
Figure 36. By Application, Global Assisted Reproductive Drugs Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Assisted Reproductive Drugs Revenue Market Share, 2018-2029
Figure 38. By Application, Global Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Assisted Reproductive Drugs Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Assisted Reproductive Drugs Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Assisted Reproductive Drugs Revenue Market Share, 2018-2029
Figure 42. By Region, Global Assisted Reproductive Drugs Sales Volume Market Share, 2018-2029
Figure 43. North America Assisted Reproductive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, North America Assisted Reproductive Drugs Revenue Market Share, 2022
Figure 45. Europe Assisted Reproductive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, Europe Assisted Reproductive Drugs Revenue Market Share, 2022
Figure 47. Asia Pacific Assisted Reproductive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country/Region, Asia Pacific Assisted Reproductive Drugs Revenue Market Share, 2022
Figure 49. South America Assisted Reproductive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country, South America Assisted Reproductive Drugs Revenue Market Share, 2022
Figure 51. Middle East & Africa Assisted Reproductive Drugs Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. U.S. Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 53. By Company, U.S. Assisted Reproductive Drugs Market Share, 2022
Figure 54. By Type, U.S. Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 57. By Company, Europe Assisted Reproductive Drugs Market Share, 2022
Figure 58. By Type, Europe Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 60. China Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 61. By Company, China Assisted Reproductive Drugs Market Share, 2022
Figure 62. By Type, China Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 65. By Company, Japan Assisted Reproductive Drugs Market Share, 2022
Figure 66. By Type, Japan Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 69. By Company, South Korea Assisted Reproductive Drugs Market Share, 2022
Figure 70. By Type, South Korea Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 73. By Company, Southeast Asia Assisted Reproductive Drugs Market Share, 2022
Figure 74. By Type, Southeast Asia Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 76. India Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 77. By Company, India Assisted Reproductive Drugs Market Share, 2022
Figure 78. By Type, India Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Assisted Reproductive Drugs Sales Volume, 2018-2029, (K Units)
Figure 81. By Company, Middle East & Asia Assisted Reproductive Drugs Market Share, 2022
Figure 82. By Type, Middle East & Asia Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Assisted Reproductive Drugs Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets